OncoPep, Inc. was founded in 2010 to commercialize a novel approach to developing targeted immunotherapeutics against cancer. The Company's proprietary core technology was developed in the laboratory of Dr. Kenneth Anderson, M.D., a world leader in cancer treatment, at the Dana Farber Cancer Institute.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 04/26/12 | $2,520,000 | |||
| 08/28/14 | $6,900,000 | Series B |
The Leukemia & Lymphoma Society | undisclosed |
| 12/09/21 | $11,000,000 | Series D |
CrystalBioScience Kukje Pharma SX Company Tera Science | undisclosed |
